Downregulation of ZCCHC4 leads to increased sensitivity of ESCC cells to cisplatin, and inhibits the proliferation and promotes apoptosis of esophageal cancer cells, potentially via the ROS/c-myc axis. This evidence concerns the gene MYC and esophageal cancer.